Background: There is a paucity of literature about prognostic evaluation for patients with breast cancer (BC) and bone metastasis at presentation. To date, little is known about how to accurately predict the prognosis of BC patients with bone metastasis at presentation. Thus, an accurate prediction tool of prognosis in this population is urgently needed. Our goal is to construct novel and prognostic nomograms for BC patients with bone metastasis at presentation.
Methods: We searched Surveillance, Epidemiology, and End Results (SEER) database for BC patients with bone metastasis at presentation between 2010 and 2016. Multivariate analysis was performed to obtain significantly independent variables. Then, novel prognostic nomograms were constructed based on those independent predictors.
Results: Tumor grade, histological type, primary tumor size, tumor subtype, surgery, chemotherapy and number of metastatic organs except bone were recognized as significantly independent variables of both overall survival (OS) and cancer-specific survival (CSS). Then those significant variables were integrated to construct nomograms for 3- and 5-year survival. Calibration plots for the 3- and 5-year survival in training and validation sets showed that the prediction curve was close to a 45 degree slash. The C-indices of OS in training and validation cohorts were 0.705 and 0.678, respectively. Similar results were observed for CSS in training and validation cohorts.
Conclusions: Our proposed nomograms can effectively and accurately predict the prognosis of BC patients with bone metastasis at presentation, which provide a basis for individual treatments for metastatic lesions.
Keywords: Breast cancer (BC); bone metastasis; nomogram; predictor; prognosis.
2020 Annals of Translational Medicine. All rights reserved.
Conflict of interest statement
Conﬂicts of Interest: The authors have no conflicts of interest to declare.
Identifying the Prognosis Factors and Predicting the Survival Probability in Patients with Non-Metastatic Chondrosarcoma from the SEER Database.Orthop Surg. 2019 Oct;11(5):801-810. doi: 10.1111/os.12521. Orthop Surg. 2019. PMID: 31663279 Free PMC article.
Can a Nomogram Help to Predict the Overall and Cancer-specific Survival of Patients With Chondrosarcoma?Clin Orthop Relat Res. 2018 May;476(5):987-996. doi: 10.1007/s11999.0000000000000152. Clin Orthop Relat Res. 2018. PMID: 29470233 Free PMC article.
Nomogram-Predicted Survival of Breast Cancer Brain Metastasis: a SEER-Based Population Study.World Neurosurg. 2019 Aug;128:e823-e834. doi: 10.1016/j.wneu.2019.04.262. Epub 2019 May 13. World Neurosurg. 2019. PMID: 31096027
Nomograms predicting survival for all four subtypes of breast cancer: a SEER-based population study.Ann Transl Med. 2020 Apr;8(8):544. doi: 10.21037/atm-20-2808. Ann Transl Med. 2020. PMID: 32411767 Free PMC article.
Development and Validation of a Prognostic Nomogram for Extremity Soft Tissue Leiomyosarcoma.Front Oncol. 2019 May 1;9:346. doi: 10.3389/fonc.2019.00346. eCollection 2019. Front Oncol. 2019. PMID: 31119101 Free PMC article.